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Abstract 
Meningitis is a disease that can be caused by a variety of factors such as bacteria, viruses, or funguses. Occasionally, in the dangerous type 
of meningitis caused by bacteria, meningitis passes through the mucous membrane, enters the bloodstream, and causes various severe 
clinical syndromes, the most common of which is acute meningitis. Complications include hearing loss, vision loss, and memory 
impairments or even death. Despite bacterial treatment, at least 10% of patients, most of whom are young children, die within 1 or 2 
days of onset, and 10 -20% of survivors face significant neurological consequences. Patients with meningitis should be identified 
immediately and the cause of the disease should be correctly identified. Various methods are used, including biochemical blood tests and 
spinal cord fluid analysis. This review article will first examine the bacteria that cause meningitis in humans and then samples of 
cerebrospinal fluid and detection will be discussed. 
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Meningitis is a disease in which the membrane covering the brain 
and spinal cord become inflamed. This inflammation is caused by 
infection of the tissue around the brain and spinal cord by 
bacterial or viral agents and causes symptoms such as headache, 
fever and neck stiffness. 90% of the disease occurs in childhood 
and can be associated with children for many years. Meningitis is 
one of the deadliest and most highly morbid diseases in children. 
The reason for the greater involvement of children with this 
disease can be considered the weakness of their immune system 
compared to adults [1, 2]. 
It should be noted that meningitis does not cause additional 
involvement in the central nervous system like diseases such as 
encephalitis and myelitis. Meningitis is one of the diseases that 
has relatively high rates of death and complications. The 
incidence of meningitis in the world is estimated at 20 per 
100,000 people per year. The most obvious symptom is a 
headache, but most children do not have a specific symptom or 
have a fever just before the onset of systemic manifestations. 
Also in the United States, the disease kills 2,000 people a year. 
Naturally, the mortality rate due to meningitis is higher in less 
developed countries [3, 4]. Meningitis can be caused by viruses, 
bacterial infections, rickettsiae, spirochetes, protozoa, fungi, and 
some intracranial drugs and tumors [2]. 
Most patients with untreated viral meningitis recover in a few 
weeks, however meningitis can be life-threatening and require 
immediate treatment. If bacterial meningitis is not treated 
quickly, it can cause brain problems such as deafness, blindness, 
neurological disorders, decreased level of consciousness, 
paralysis and even death of the patient [5, 6]. 
Early symptoms of viral meningitis and bacterial meningitis can 
be similar. However, the symptoms of this bacterial disease are 
usually more severe and can vary depending on the patient's age. 
Clinical symptoms in patients with meningitis progress within a 
few hours to a few days or over weeks to months [1]. Viral 
infections are more common with meningitis, but since bacterial 
infections can be life-threatening, it is more important to identify 
the cause of the disease. Early diagnosis and treatment of 
meningitis is vastly important in helping patients [7]. 
 
Meningitis 
Mortality rate in viral meningitis is very low and most patients 
recover, but in bacterial meningitis, depending on the type of 
bacterium, it could kill 10% to 25% if left without appropriate 
treatment. Also, depending on the patient's age, underlying 
disease, and surgery on the nervous system, different bacteria 
cause different symptoms in the patient. Bacterial meningitis is 
contagious and is caused by a specific bacterial infection that 
could be fatal if left untreated. 
Symptoms of bacterial meningitis are sudden and include 
headache, sore throat, runny nose, cough, and conjunctivitis. 
Symptoms such as nausea, vomiting, fever and chills, arthralgia 
and myalgia also show up when the disease enters its more 
severe phase. Fever was severe in these patients and was 
reported to be between 39 and 41 degrees [1, 2]. 
Bacteria enter the bloodstream and travel to the brain and spinal 
cord, causing acute bacterial meningitis. Also, possibly there is 
the risk of infection in the ear or sinuses, trauma or rarely after 
surgery, bacteria can directly invade the meninges of the brain. 
The most important bacteria that cause meningitis are 
Escherichia coli, Haemophilus influenzae, Streptococcus 
pneumoniae, Neisseria meningitidis and Listeria. Observations 
show that more than 80% of the disease is caused by 
Haemophilus influenzae, Streptococcus pneumoniae, and 
Neisseria meningitidis [8]. In another decade-long study of 
workers in Birmingham, the bacteria Neisseria meningitidis were 
identified as the most common pathogen causing meningitis, 
Haemophilus influenzae as the second most common cause, and 
pneumococcus as the third most common cause of meningitis [9]. 
A report by Ali Akbar Heydari et al., at Imam Reza Hospital, 
Mashhad, Iran, found that if meningitis lasted more than a week 
and a cerebrospinal fluid test showed a decrease in sugar levels 
and an increase in protein levels, it could be due to tuberculosis 
and Brucellosis and it should also be considered [10]. 
Tuberculous meningitis is the most dangerous extrapulmonary 
form of tuberculosis and it could be seen in 7 to 12% of TB 
patients in developing countries. In most cases, this meningitis is 
chronic]11  [ . If left untreated, the mortality rate in these patients 
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is high, in addition in 20 to 25 percent of patients who were 
treated late, neurological side effects have been observed [12, 
13]. Common bacteriological methods are not suitable for the 
correct diagnosis of this disease, and usually false-negative 
results are obtained from these methods. However, tuberculous 
meningitis is one of the most urgent infectious diseases and 
requires immediate and early diagnosis [14]. 
 
Streptococcus pneumoniae (pneumococcus) 
Streptococcus pneumoniae is the most common cause of 
meningitis in infants, children, and adults. Today, despite the 
significant advances in treatment and vaccination, mortality rate 
from pneumococcal meningitis is 16 to 37 percent, and 
neurological complications including hearing loss, focal 
neurological impairment, and cognitive impairment are 
estimated to occur in 30 to 52 percent of residual patients [15, 
16]. 
The human nasopharynx is the main reservoir of pneumococcus, 
and bacteria are usually found there without symptoms. The 
highest rate of pneumococcus among children is 37 percent and 
may increase to 58 percent in crowded places such as day care 
centers. In adults, overcrowding may also lead to an increase, for 
example in hospitals, long-term care centers, shelters and 
prisons, the rate of bacterial carriers were reported to be up to 
40% [17, 18]. 
The bacterium is mainly transmitted through coughing and 
sneezing. In patients with diseases such as sickle cell disease, 
multiple myeloma, hypogammaglobulinemia, alcoholism, chronic 
liver or kidney disease, malignancy, thalassemia major, diabetes 
mellitus, basal cell skull fractures with cerebrospinal fluid 
leakage, and also in children using cochlear implants, Immune 
system suppressants, diabetes and HIV infection, pneumococcal 
meningitis could occur possibly. [7, 19, 20]. 
Laminin appears to be involved in the binding of endothelial 
microvascular cells in the brain. In a study of mice, Pneumococcal 
surface Protein C (PspC) mutations reduced the frequency of 
pneumococcal meningitis. These results suggest that the 
interaction between laminin and pneumococcal PspC plays an 
important role in the intracellular transfer of pneumococci 
through the blood brain barrier [21]. 
 
Escherichia coli 
Despite therapeutic advances against microbes and supportive 
cares, meningitis caused by gram-negative bacilli is still one of 
the leading causes of death worldwide. The mortality rate is 
between 15 and 40 percent, and approximately 50 percent of the 
survivors have neurological complications [22]. 
Escherichia coli is the most common gram-negative organism 
that causes meningitis, especially in infancy. Most cases of 
Escherichia coli meningitis are spread by blood transfusions [23]. 
Diabetes and surgery are predisposing factors for Escherichia 
coli meningitis [24, 25]. This type of meningitis is also more 
likely to occur after severe infections caused by Strongyloides 
stercoralis in infants, the elderly, people with weakened immune 
systems, and patients with gram-negative septicemia. 
Unfortunately, the findings of a 2005 study by Yang et al. Show 
that the negative gram-negative meningitis caused by 
Escherichia coli is greatly increasing [25]. 
Escherichia coli infiltration of the blood-brain barrier is an 
important factor in the progression of meningitis. Bacteria can 
cross the blood-brain barrier intracellularly, extracellularly, or 
through infected phagocytic cells. Successful passage of the 
bacterium requires a high level of bacterial concentration, and in 
addition binding and attacking Human Brain Microvascular 
Endothelial Cells (HBMEC). After the Escherichia coli bacterium 
penetrates the blood-brain barrier, bacterial meningitis is 
characterized by meninges inflammation, which occurs in 
response to bacteria and bacterial products, resulting in the 
release of cytokines and chemokines, as well as 
pathophysiological changes, including leukocyte infiltration and 
dysfunction of the blood-brain barrier [26, 27]. Studies have 
shown that the mechanisms involved in microbial invasion into 
the blood-brain barrier are different from the response to 
meningitis-causing pathogens in the release of cytokines and 
chemokines. For example, interleukin secretion (IL-8) occurs in 
Escherichia coli response in HBMEC, but would not occur in non-
cerebral endothelial cells [28, 29].  
It should be noted that the lack of specific and appropriate 
antibiotic intake in gram-negative meningitis is always 
associated with mortality in patients. Studies have shown that 
the mortality rate with specific antibiotic intake is between 28 
and 40 percent. Despite the high mortality rate with timely 
diagnosis and appropriate treatment, patient mortality could be 
prevented. Predisposing factors for Escherichia coli meningitis 
include infectious shock, decreased level of consciousness during 
hospitalization, diffuse intravascular coagulation, hyperglycemic 
coma, high lactate levels in CSF, and leukocytosis [30, 31]. 
 
Meningococcus 
In 1987, Weichselbaum was the first person to detect and 
diagnose meningococcus in cerebrospinal fluid (CSF) in a patient 
with meningitis [32]. The human species are the only natural 
host of meningococcus. Meningococcus has created several 
mechanisms that are able to transmit, adapt, and colonize most 
of the mucosal surfaces of the human upper respiratory tract. 
Some meningococcal colon groups also have the capacity to 
cause invasive disease. These bacteria usually cause upper 
respiratory infections and are highly contagious infections that 
mainly affect adolescents and adults [33, 32]. 
The invasive factors of meningococci are due to the interaction of 
microbial agents affecting the severity of the organism, the 
environmental conditions that facilitate exposure to bacteria, and 
the host susceptibility factors to bacteria, invasion and survival. 
Meningococcal disease is associated with significant 
complications such as loss of limbs, hearing loss, cognitive 
impairment, visual impairment, academic problems, growth 
retardation, motor nerve defects, seizure disorders and 
behavioral problems [33]. Treatment for meningococcal disease 
includes serum therapy and sulfonamides introduced in 1937. 
The advent of sulfonamide resistance in the 1960s created the 
first vaccines against meningococci [34, 35]. 
 
Listeria 
Listeria is a gram-positive bacillus found mainly in contaminated 
food, and after the outbreak of leukemia in the 1980s, Listeria 
monocytogenes is the third most common cause of bacterial 
meningitis [36]. Meningitis caused by Listeria has been described 
as a disease in immunocompromised patients and the elderly 
with a high mortality rate. As many studies have shown, the 
incidence of healthy children with this disease is less than 6% 
[37]. 
In patients with meningitis infected with Listeria fever, neck 
stiffness and altered mood were reported in 43% of patients, and 
in almost all patients at least 2 of the 4 symptoms of headache, 
fever, neck stiffness, and altered mood were observed. [38]. Also, 
many adults with Listeria meningitis had atypical CSF findings, 
and only 23% of patients did not have any bacterial-based CSF 
findings [37]. For the treatment of suspected bacterial 
meningitis, amoxicillin-based antimicrobial therapy is 
recommended for patients over the age of 50 or with risk factors 
to cover Listeria, as the bacterium is resistant to cephalosporins 
[39]. 
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The bacterium Haemophilus influenzae lives in the nasopharynx 
and is usually harmless. However, bacteria can sometimes spread 
to other parts of the body and cause infections. Haemophilus 
influenzae serotype B (HIB) was a major cause of meningitis in 
children until an effective vaccine was given to treat it. Currently, 
most cases of Hemophilus influenzae meningitis occur in adults 
in undescribed strains [40]. All antigenic serotypes can cause 
invasive disease, which is more commonly reported in pediatric 
patients. Non-capsule strains have fewer viruses and rarely cause 
serious infections in children [41]. Hemophilus influenzae is rare 
due to childhood vaccinations and possibly herd safety. Since 
2013, national immunization programs have included the 
Hemophilus influenzae vaccine in 189 countries with about 50 
percent of the world's children's coverage. However, 
Haemophilus influenzae is the leading cause of meningitis among 
unvaccinated children, especially in developing countries. 
Meningitis rash is more common in meningitis infections, which 
is now the most common cause of meningitis in some countries 
and often occurs with septicemia [40, 41]. 
 
Immune activation and inflammatory response in the brain 
Inflammation as an important and fundamental mechanism in 
the field of neurological disorders is caused by various causes, 
but its role in changing brain’s function as a result of infectious 
neurological diseases is unclear. Several studies have shown that 
eradicating pathogens within the central nervous system (CNS) 
may require immune responses that interfere with the function 
of nerve cells and communication without affecting their 
survival. During infectious neurological diseases, innate immune 
molecules such as complementary proteins and cytokines 
regulate synaptic flexibility and neurogenesis, while amyloid β 
and α-synuclein and biological markers of neurological disease 
play an antimicrobial role [42, 43]. 
The penetration of neutrophils into the scapular chamber is 
highly important for the secretion of pathogens, but leads to the 
clinical symptoms of meningitis including headache, neck 
stiffness (meningitis) and photophobia. These symptoms are the 
result of the expression of catecholamines by phagocytes 
exposed to bacterial products that cause mydriasis and lead to 
excessive light transmission to the brain and vasospasm [44, 45]. 
High concentrations of TH1 cytokines such as IL-1β, tumor 
necrosis factor (TNF) and interferon-γ (IFN-γ) in the 
cerebrospinal fluid of patients with infectious meningitis are also 
associated with cognitive impairment [46]. During bacterial 
meningitis, monocyte-derived macrophages play a protective 
role in the central nervous system, especially meningeal 
macrophages. However, pathogens could cause neurotoxicity 
through Toll-like receptors by releasing cell death signals such as 
oxidants or activating inflammatory components such as 
caspase-1 [47]. 
 
Meningitis at different ages 
Meningitis occurs in all age groups, but infants have the highest 
risk of bacterial meningitis and meningitis, and there is another 
peak in adolescents and adults. Viral meningitis is more common 
and accounts for more than half of the cases, but bacterial 
meningitis is particularly important due to high mortality rate 
[48]. It is estimated that the average general practitioner 
observes one or two cases of bacterial meningitis during his or 
her career. The incidence of bacterial meningitis confirmed by 
bacterial culture in developed countries is estimated at 0.3 per 
1,000 live births [49]. 
Mortality from bacterial meningitis in children has been reported 
to be 20 to 30 percent, and this rate decreases with age. Children 
with bacterial meningitis may have seizures or reddish-purple 
spots on their skin. The most common bacteria that cause 
meningitis in infants are gram-negative bacilli and group B 
strains and listeria. In infants over one month of age, 
Haemophilus influenzae and Neisseria meningitidis have been 
reported to be the most common causes of meningitis. Also, in 
adults, most patients were diagnosed with meningococcus and 
pneumococcus [50]. 
Bacterial meningitis is very dangerous and deadly and requires 
timely diagnosis, even though other types of meningitis are rare 
and not considered a major risk. To diagnose bacterial meningitis 
from the other types, spinal cord fluid culture is required, and the 
patient's chances of dying or other complications are high during 
SPF culture and response. For this reason, methods that could 
quickly diagnose the disease are highly needed. 
 
Diagnosis methods 
Infectious meningitis may be caused by bacterial, mycobacterial, 
fungal, or viral agents. In the diagnosis of meningitis, several 
cases of the patient's history and symptoms should be 
considered along with regional epidemiology and initial CSF test 
(protein, etc.) so that the physician could consider the possibility 
of disease and rationally choose additional diagnostic tests. 
Bacterial culture is often the main basis for diagnosis. 
CT and MRI may be used as adjunctive diagnostic tests to identify 
meningitis, but are generally non-specific. Imaging might be 
helpful in cases of focal neurological defects, especially when you 
suspect tuberculosis or cryptococcus. In the absence of trauma, 
mood swings or focal neurological impairment, imaging 
increases the cost of health care and minimizes performance in 
providing a definitive diagnosis. The standard diagnostic test for 
cerebrospinal fluid includes white blood cell counts, total 
protein, and blood sugar, which are used in connection with the 
patient's history and epidemiology to support possible 
diagnoses. The total amount of protein and the number of white 
blood cells reflect inflammation in the cerebrospinal fluid, while 
a decrease in the ratio of cerebrospinal fluid glucose to blood 
glucose is a sign that glucose is being consumed by an active 
infection. These common laboratory tests may not be a perfect 
laboratory method, as different amounts of different diagnoses 
overlap but generally help the doctor focus on specific diagnoses. 
 
Cerebrospinal fluid sampling (LP) 
The most important and accurate way to correctly diagnose 
meningitis is to take a sample of cerebrospinal fluid. Lumbar 
puncture (LP) is used to take a sample and the person will not 
have many side effects if done correctly. This method is one of 
the most accurate methods of diagnosing the disease, which 
requires 18 to 24 hours, and for some reason, a small number of 
cases of bacterial meningitis can be identified with this method 
[51]. 
The CSF values of bacterial meningitis in adults are as follows. 
The amount of cerebrospinal fluid leukocytes is 494 / microliter, 
80% neutrophil, 2.45 g / l protein and 0.36 blood sugar level. If 
the level of liquid sugar is low, its protein has increased and the 
level of its white blood cells is high, it is a sign of meningitis. The 
appearance of the cerebrospinal fluid itself is also an important 
factor in the diagnosis of meningitis. In 100% of people with the 
disease, the fluid is turbid. Which can occur due to increased 
leukocytes. Pleocytosis is also almost always present in most 
patients, and the number of white blood cells varies from 100 to 
1000 cells per microliter [2, 51]. 
Based on the studies of cerebrospinal fluid bacteria could be 
detected by the presence of inflammatory cells, bacterial 
antigens and bacterial culture in the cerebrospinal fluid sample. 
In the early stages of the disease, headache, mild fever, and some 
degree of mood swings and forgetfulness occur in young patients 
and high mortality in adult patients. Examination of the 
cerebrospinal fluid in these patients showed that the single-
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nucleated white blood cells had increased sharply, the sugar had 
decreased markedly, and the protein had increased [2]. 
 
Risk Factor Score 
Symptoms of meningitis may have other causes. Many clinical 
signs and symptoms and laboratory tests of blood and 
cerebrospinal fluid in meningitis are examined, but none of these 
are completely different in terms of the presence or absence of 
bacterial meningitis. Because delaying the diagnosis and 
treatment of bacterial meningitis makes the treatment more 
difficult, doctors have little amount of time to perform LP and 
start antibiotic treatment of bacterial meningitis in children. On 
the other hand, performing LP and experimental treatment of 
these children may be considered somewhat unnecessary later 
[52]. The two main problems we face are that to ensure the 
presence or absence of bacterial meningitis, which makes it 
necessary to perform LP, and on the other hand, based on direct 
examination of cerebrospinal fluid data, antibiotics must be used 
until cultivation is available [53]. 
There is no doubt that bacterial meningitis is a dangerous 
disease for humans. Clinical deterioration in the disease can 
occur rapidly and is often difficult to predict. A risk ranking can 
be useful in assessing the risk and subsequent management of 
patients [54]. Researchers are trying to identify bacterial 
meningitis predictors to estimate the risk of the disease and to 
avoid unnecessary testing by correctly identifying people who 
need immediate treatment, as well as reducing the extra cost on 
families and communities. There are different rules for using this 
tool. Some of them include complex multivariate models that are 
needed to perform on computers, and the doctor cannot easily 
diagnose the disease with their help. Others use a simple scoring 
system that scores definite signs and symptoms which is more 
appropriate for use in the treatment process [55, 54]. 
In one study, the number of leukocytes, cognitive impairment 
and infection with Streptococcus pneumoniae were collected as 
prognostic factors in adults with bacterial meningitis. The aim of 
this study was to extract and validate a simple scoring system for 
predicting meningitis. This ranking makes it clear that patients 
with bacterial meningitis can be classified in the early stages. The 
results confirmed that the model could not completely 
differentiate between patients with meningitis and healthy [55]. 
The bacterial meningitis score is a rule for the clinical prognosis 
of children with CSF pleocytosis who have a very low risk of 
bacterial meningitis. Bacterial meningitis scores for children with 
CSF pleocytosis who have not undergone neurosurgery, have not 
been associated with any disease, and no antibiotic pre-
treatment has been achieved in 72 hours after the LP, were very 
low [56]. Those who did not have any high-risk laboratory 
predictions were classified as having very low risk for bacterial 
meningitis. In a study of children, the system could finely classify 
bacterial meningitis as well, but with very few features. 
According to the study, a small minority of infants with CSF 
pleocytosis were classified as very low-risk due to their bacterial 
meningitis score. Careful supportive decision-making tools for 
children with CSF pleocytosis with a risk of bacterial meningitis 
close to zero using clinical and laboratory parameters were 
readily available at the time of clinical presentation and could 
guide physicians, also limit unnecessary hospitalizations and 
long-term use of antibiotics [56, 55]. 
New methods for classifying risk are needed to accurately 
identify infants with bacterial meningitis from low-risk 
individuals. Neither clinical grading algorithms nor complete 
blood counts are suitable for this purpose, and they do not 
accurately identify infants at low risk for bacterial infections, 
including bacterial meningitis [57]. 
Oostenbrink rules are potentially very useful to physicians 
because they are simple and could help us make decisions about 
LP and treat patients experimentally with antibiotics (Table 1). A 
Oostenbrink rules based study of 226 children in four Dutch 
hospitals found that two out of 25 children with meningitis had a 
grade point average of less than 9.5. One in two children had 
symptoms of meningitis and prolonged seizures. None of the 
other 205 children with a score of less than 8.5 had bacterial 
meningitis. 13% had the disease with a score between 8.5 and 
14.9. In 52%, the disease was observed with a score of 15.0 to 
19.9; Also, 87% of people with a score of 20.0 or more had 
meningitis. Using this law, the number of hospitalizations was 
reduced by 33% in the hospital, and unnecessary LPs were 
prevented from occurring in 5% of individuals, and additional 
financial costs to the individual and the community were 
significantly reduced [58]. 
 
Table 1. Oostenbrink rules for predicting the risk of bacterial meningitis in children with 
meningitis symptoms 
Score Risk factor 
1month-15years 
1.0 per day (10 maximum) 
Patients age 
The duration of the patient's problem 
2.0 History of vomiting 
6.5 Cyanosis 
8.0 Disturbed consciousness 
7.5 Meningeal irritation * 
4.0 Petechiae 
 Serum concentration of reactive protein 
C (mg / l or deciliters) 
0           <5.0 (50) 
0.5   5.0-9.9(50-99) 
1.0 10.0-14.9 (100-149) 
1.5 15.0-19.9 (150-199) 
2.0 >20.0 (200) 
total  
 
Brudzinski's symptom (passive bending of the neck towards the 
chest causes the knees and hips to bend); Kernig's sign 
(stretching of the lower leg when the thigh is bent toward the 
trunk at a 90-degree angle is painfully limited); Tripod position 
(legs bent and arms stretched at the elbow) while sitting. Or neck 
stiffness, irritability while moving the head or legs, as well as 
prominent Fontanel may be seen in children under one year of 
age. 
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The minimum age according to Stenbrink's criteria should be 
more than one month, and children whose score is 8.5 or higher 
should be LP. Nigrovic's law is preferable to Oostenbrink because 
it is easier to use and 66 percent more specific (Table 2); A study 
of 12 children with a score of less than 8.5 using Stenbrink's law 
found bacterial meningitis, and their disease was identified by 
Nigrovic's law [59]. 
 
Table 2. Nigrovic scoring rules for identifying people with meningitis 
Risk factor 
Gram-positive staining of cerebrospinal fluid 
Level of cerebrospinal fluid protein< 80 mg / dL (800 mg / L) 
Total number of side neutrophils<10,000 cells per cubic millimeter (109 x 10 liters) 
Seizure 
Total amount of cerebrospinal fluid neutrophils< 1000 cells per cubic millimeter (1 × 109 per liter) 
Bacterial meningitis samples / total patients (%) 
Nigrovic 2007 6 200 Nigrovic 2002  Nigrovic Number of risk factors 
2.1, 714 (0.1) 0.86 (0) 0.144 (0) 0 
119.1 , 189 (10) 20.65 (31) 38.90 (42) 1or moe 
 
CONCLUSION AND PERSPECTIVE 
Meningitis, if left untreated, can lead to serious complications 
and even death. Therefore, early and accurate diagnosis is one of 
the research priorities of this disease. There are many methods 
available, such as examining the patient's clinical symptoms, 
performing MRI and CT scans, biochemical blood tests, and 
examining the cerebrospinal fluid. The most appropriate method 
available is to examine the cerebrospinal fluid, which requires a 
hole in the patient's back. Researchers have used scoring 
methods to quickly identify patients, prevent unnecessary 
treatment or performing LP. It could be said that Ningrovic and 
Oostenbrink laws have the best balance between validity and 
ease of use. These rules should not be completely trusted. For 
example, seizures are relatively rare and do not meet statistical 
criteria for entering the Oostenbrink law. However, any child 
with suspected meningitis and seizures should have an LP. All 
suspected children with meningitis must be closely monitored, 
whether LP or experimental treatment [60]. 
In recent years, penicillin, chloramphenicol, and sulfadiazine 
antibiotics have been used to treat meningitis. With the 
introduction of stronger antibiotics, studies have been conducted 
to change traditional drug regimens in use and replace them with 
newer drug regimens that have been more effective and safer. A 
1991 study by Nabil et al., found that ampicillin and third-
generation antibiotics such as ceftriaxone cephalosporins were 
highly effective in treating acute bacterial meningitis [61]. It 
should be noted that these medications do not apply to 
meningitis in immunocompromised individuals, neonatal 
meningitis or tuberculous meningitis. Unfortunately, due to the 
increase in the uncontrolled use of antibiotics, the emerging 
phenomenon of antibiotic resistance against this disease is also 
observed. 
Hopfully by using appropriate methods and approaches, 
meningitis will be identified quickly and correctly and will be 
effectively treated over time to prevent side effects and death, as 
well as reduce additional costs on families and the community. 
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